Showing results (191-200 of 266) with videos related to
Sort By:
Pageof 27
Neuro-Oncology Advances|February 4, 2025
High-dose MTX-based polychemotherapy for primary CNS lymphoma in younger patients: Long-term efficacy of the modified Bonn protocolThomas Zeyen, Johannes Weller, Matthias Schneider, et al.Rheumatology (Oxford, England)|May 17, 2024
Transorbital ultrasound in the diagnosis of giant cell arteritisSimon M Petzinna, Lara C Burg, Claus-Juergen Bauer, et al.Clinical Epigenetics|November 22, 2019
Molecular and immune correlates of TIM-3 (HAVCR2) and galectin 9 (LGALS9) mRNA expression and DNA methylation in melanomaTobias A W Holderried, Luka de Vos, Emma Grace Bawden, et al.Oncoimmunology|September 19, 2017
Targeting myeloid derived suppressor cells with all-trans retinoic acid is highly time-dependent in therapeutic tumor vaccinationAnnkristin Heine, Chrystel Flores, Heidrun Gevensleben, et al.Cancer Research|June 3, 2006
Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patientsJan Wierecky, Martin R Müller, Stefan Wirths, et al.Oral Oncology|August 19, 2019
Nivolumab versus investigator's choice in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety in CheckMate 141 by ageNabil F Saba, George Blumenschein, Joel Guigay, et al.Cancer Research|February 12, 2004
Induction of adipophilin-specific cytotoxic T lymphocytes using a novel HLA-A2-binding peptide that mediates tumor cell lysisSusanne M Schmidt, Kerstin Schag, Martin R Müller, et al.Frontiers in Digital Health|November 5, 2024
Unleashing the potential of eHealth in outpatient cancer care for patients undergoing immunotherapy-a quantitative study considering patients' needs and current healthcare challengesTobias A W Holderried, Isabel Stasik, Marie-Therese Schmitz, et al.HIV Medicine|November 5, 2025
Effective and safe use of immune checkpoint inhibitors for non-small cell lung cancer in people living with HIVRebekka Mispelbaum, Tessa Hattenhauer, Christian Hoffmann, et al.International Journal of Cancer|July 20, 2016
Targeting DDR2 in head and neck squamous cell carcinoma with dasatinibAnne von Mässenhausen, Christine Sanders, Johannes Brägelmann, et al.Pageof 27